Stem Cell Transplantation
High-dose chemotherapy with ASCT beneficial for bone and soft-tissue sarcomas
Published in Immunotherapy Weekly, September 8th, 2004
According to a study from Germany, "The role of high-dose chemotherapy (HDCT) with PBSCT in the treatment of bone and soft-tissue sarcomas is not established.
"In total, 27 patients (15 female, median age at TPL 30.6 years (range: 13-59)) were analyzed (Ewing sarcoma family n=8, osteosarcoma n 6, MPNST (malignant peripheral nerve sheath tumor) n=4, synovial sarcoma n=3, liposarcoma n=2, leiomyosarcoma n=2, rhabdomyosarcoma n=1, meningosarcoma n=1)."
"Following chemotherapy and surgery complete remission (CR)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2004-09-08)
More Articles from Immunotherapy Weekly
- AIDS/HIV Vaccine
Hemagglutinating virus protein induces immune response with HIV vaccine - Allergies
Softening agent from PVC cause of asthma and allergic symptoms among children - Skin Cancer
Malignant melanomas increasing in teenagers and young adults - Tuberculosis Vaccine
New vaccines against tuberculosis entering human clinical trials - Vaccine Development
New evidence on antigen presenting cells and antigens reviewed - AIDS Therapy
Patient enrollment completed in phase I/II trial in AIDS - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
